OACC
Oaktree Acquisition Corp. III Life Sciences
$10.69
+0.00 (+0.00%)
At close · Jul 7
Market Cap
$262.79M
Shares
24,582,768
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.69
Open$10.69
Day$10.69–10.69
52W$10.30–10.74
Avg vol 30d21K
Short int29K · 0.1% float · 4.6d
Short vol4%
DataDec 2024–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+1%
above
Price vs 50-day avg
+0%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
89%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
0%
trailing
YTD return
+1%
this year
Relative strength
−7%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +6.8% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
51 holders — near 1-yr high, broad support
Squeeze score
63
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
5%
annualized · 1-yr
Max drawdown
−2%
past year
ATR
0.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+1%
Bullish
Price vs 50-day avg
+0%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
89%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +6.8% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
51 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $10
Now $11 · 89%
52-wk high $11
vs 200-day avg +1%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OACC
this stock
Oaktree Acquisition Corp. III Life Sciences
|
$262.79M | +1.0% | — | — | 0.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | +0.0% | — | 100.2 | — |
|
XXI
Twenty One Capital, Inc.
|
$3.58B | -37.2% | — | — | 0.9% |
|
CCXI
Churchill Capital Corp XI
|
$883.40M | — | — | — | 0.0% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$643.37M | +2.0% | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OACC | -0.1% | +0.4% | +0.5% | -0.1% | +1.0% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -1.0% | -1.0% | -7.1% | -0.2% | -8.6% |